Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Daphna Joel
Incorporating Sex as a Biological Variable in Neuropsychiatric Research: Where Are We Now and Where Should We Be?
Neuropsychopharmacology
Psychiatry
Mental Health
Pharmacology
Analysis of Human Brain Structure Reveals That the Brain “Types” Typical of Males Are Also Typical of Females, and Vice Versa
Frontiers in Human Neuroscience
Mental Health
Neuropsychology
Physiological Psychology
Neurology
Behavioral Neuroscience
Psychiatry
Biological Psychiatry
Selective Alleviation of Compulsive Lever-Pressing in Rats by D1, but Not D2, Blockade: Possible Implications for the Involvement of D1 Receptors in Obsessive–Compulsive Disorder
Neuropsychopharmacology
Psychiatry
Mental Health
Pharmacology
Enhancement of Excessive Lever-Pressing After Post-Training Signal Attenuation in Rats by Repeated Administration of the D-Sub-1 Antagonist SCH 23390 or the D-Sub-2 Agonist Quinpirole, but Not the D-Sub-1 Agonist SKF 38393 or the D-Sub-2 Antagonist Haloperidol.
Behavioral Neuroscience
Behavioral Neuroscience
Related publications
Neuropsychiatric Outcomes After Stroke – Authors' Reply
The Lancet Neurology
Neurology
Maximising the Value of Research for Brain Health
The Lancet Neurology
Neurology
Cannabidiol in Patients With Treatment-Resistant Epilepsy
The Lancet Neurology
Neurology
WHO Takes Up the Baton on Dementia
The Lancet Neurology
Neurology
Learning About the Brain With Comics
The Lancet Neurology
Neurology
Functional (Psychogenic) Saccadic Oscillations and Oculogyric Crises – Authors' Reply
The Lancet Neurology
Neurology
Dream Weaver
The Lancet Neurology
Neurology
The Evolution of Universally Accessible Building Design
The Lancet Neurology
Neurology
Global, Regional, and National Burden of Meningitis, 1990–2016: A Systematic Analysis for the Global Burden of Disease Study 2016
The Lancet Neurology
Neurology
Intravenous Immunoglobulin for Treatment of Mild-To-Moderate Alzheimer's Disease: A Phase 2, Randomised, Double-Blind, Placebo-Controlled, Dose-Finding Trial
The Lancet Neurology
Neurology
